Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 3,500 peer-reviewed publications. The CPRD bibliography listed below is updated on a monthly basis (last updated 8 May 2024).

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: CPRD bibliography PDF March 2024 (PDF, 4.2MB, 313 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

Page last reviewed
Year Sort ascending Title
2022

Antipsychotic treatment patterns in Alzheimer's disease patients with agitation: a cohort study using the UK clinical practice research datalink

10.1080/03007995.2022.2029381

Authors: C. Tran, M. Bøg, S. Collings, M. Johnson, N. Qizilbash, S. Lind, R. Baker, K. Jørgensen

2022

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension

10.1177/02698811221082470

Authors: T. van Sloten, P. Souverein, C. Stehouwer, J. Driessen

2022

Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety

10.1080/15412555.2022.2035705

Authors: S. Suissa, S. Dell'Aniello, P. Ernst

2022

Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice

10.1080/15412555.2022.2045265

Authors: S. Suissa, S. Dell'Aniello, P. Ernst

2022

Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors

10.1016/j.canep.2022.102149

Authors: A. van Veelen, S. Abtahi, P. Souverein, J. Driessen, O. Klungel, A. Dingemans, R. van Geel, F. de Vries, S. Croes

2022

Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis

10.1136/bmj-2021-068373

Authors: X. Li, B. Raventós, E. Roel, A. Pistillo, E. Martinez-Hernandez, A. Delmestri, C. Reyes, V. Strauss, D. Prieto-Alhambra, E. Burn, T. Duarte-Salles

2022

Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysis

10.1016/j.eclinm.2022.101392

Authors: D. Morales, D. Moreno-Martos, N. Matin, P. McGettigan

2022

Does co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?

10.1111/bcp.15371

Authors: L. Penner, S. Gavan, D. Ashcroft, N. Peek, R. Elliott

2022

Associations between multiple long-term conditions and mortality in diverse ethnic groups

10.1371/journal.pone.0266418

Authors: M. Stafford, H. Knight, J. Hughes, A. Alarilla, L. Mondor, Pefoyo Kone, W. Wodchis, S. Deeny

2022

Clustering of physical health multimorbidity in people with severe mental illness: An accumulated prevalence analysis of United Kingdom primary care data

10.1371/journal.pmed.1003976

Authors: N. Launders, J. Hayes, G. Price, D. Osborn

2022

The sexual and reproductive health of women with mental illness: a primary care registry study

10.1007/s00737-022-01214-y

Authors: H. Hope, M. Pierce, E. Johnstone, J. Myers, K. Abel

2022

Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study

10.1002/cncr.34208

Authors: F. Khosrow-Khavar, L. Azoulay, J. Montastruc, F. Montastruc, C. Renoux

2022

Incretin-Based Drugs and the Incidence of Prostate Cancer Among Patients with Type 2 Diabetes

10.1097/ede.0000000000001486

Authors: S. Lu, H. Yin, O. H. Y. Yu, L. Azoulay

2022

Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort Study

10.1016/j.jaccao.2022.01.102

Authors: H. Strongman, S. Gadd, A. Matthews, K. Mansfield, S. Stanway, A. Lyon, I. dos-Santos-Silva, L. Smeeth, K. Bhaskaran

2022

Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK

10.1136/bmjopen-2021-055015

Authors: M. Danese, E. Sidelnikov, G. Villa, D. Catterick, M. Iqbal, M. Gleeson, D. Lubeck, J. Patel

2022

Development and external validation of a clinical prediction model to aid coeliac disease diagnosis in primary care: An observational study

10.1016/j.eclinm.2022.101376

Authors: M. Elwenspoek, R. O'Donnell, J. Jackson, H. Everitt, P. Gillett, A. Hay, H. Jones, G. Robins, J. Watson, S. Mallett, P. Whiting

2022

Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019

10.2147/ceor.s347085

Authors: A. Bilitou, J. Were, A. Farrer, A. Rabe, S. W. Y. Ming, I. Haq, K. Dunton

2022

Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus

10.1111/dme.14858

Authors: W. Alkabbani, A. Zongo, J. Minhas-Sandhu, D. Eurich, B. Shah, M. Alsabbagh, J. Gamble

2022

Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK

10.1007/s11606-022-07420-9

Authors: R. Baksh, A. Strydom, S. Pape, L. Chan, M. Gulliford

2022

Late effects of cancer in children, teenagers and young adults: Population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost

10.1016/j.lanepe.2021.100248

Authors: W. Chang, M. Katsoulis, Y . Y. Tan, S. Mueller, K. Green, A. Lai

2022

Impact of covid-19 on primary care contacts with children and young people aged 0-24 years in England; longitudinal trends study 2015-2020

10.3399/BJGP.2021.0643

Authors: K. Foley, E Maile, A. Bottle, F. Neale, R. Viner, S. Kenny, A. Majeed, D. Hargreaves, S. Saxena

2022

Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings

10.1007/s00125-021-05640-y

Authors: K. Dziopa, F. Asselbergs, J. Gratton, N. Chaturvedi, A. Schmidt

2022

Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)

10.1136/bmjopen-2021-060413

Authors: S. Haroon, K. Nirantharakumar, S. Hughes, A. Subramanian, O. Aiyegbusi, E. Davies, P. Myles, T. Williams, G. Turner, J. Chandan, C. McMullan, J. Lord, D. Wraith, K. McGee, A. Denniston, T. Taverner, L. Jackson, E. Sapey, G. Gkoutos, K. Gokhale, E. Leggett, C. Iles, C. Frost, G. McNamara, A. Bamford, T. Marshall, D. Zemedikun, G. Price, S. Marwaha, N. Simms-Williams, K. Brown, A. Walker, K. Jones, K. Matthews, J. Camaradou, M. Saint-Cricq, S. Kumar, Y. Alder, D. Stanton, L. Agyen, M. Baber, H. Blaize, M. Calvert

2022

Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink

10.3399/bjgp.2021.0561

Authors: C. Archer, S. MacNeill, B. Mars, K. Turner, D. Kessler, N. Wiles

2022

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

10.1136/bmjdrc-2021-002517

Authors: T. Weiss, L. Yang, R. Carr, S. Pal, B. Sawhney, R. Boggs, S. Rajpathak, K. Iglay

2022

Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes

10.2337/dc21-1113

Authors: A. Wright, M. Carr, E. Kontopantelis, L. Leelarathna, H. Thabit, R. Emsley, I. Buchan, M. Mamas, T. van Staa, N. Sattar, D. Ashcroft, M. Rutter

2022

Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study

10.14283/jpad.2022.8

Authors: B. Zheng, B. Su, C. Udeh-Momoh, G. Price, I. Tzoulaki, E. Vamos, A. Majeed, E. Riboli, S. Ahmadi-Abhari, L. Middleton

2021

Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities

10.1016/j.jaip.2021.07.056

Authors: M. Kerkhof, T. Tran, R. Allehebi, G. Canonica, L. Heaney, M. Hew, Perez de Llano, M. Wechsler, L. Bulathsinhala, V. Carter, I. Chaudhry, N. Eleangovan, R. Murray, C. Price, D. Price

2021

Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016

10.1016/j.jaci.2020.12.001

Authors: R. Silverwood, K. Mansfield, A. Mulick, A. Wong, S. Schmidt, A. Roberts, L. Smeeth, K. Abuabara, S. Langan

2021

Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study

10.1080/15412555.2021.1877649

Authors: S. Suissa, S. Dell'Aniello, P. Ernst

2021

Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety

10.1016/j.rmed.2021.106645

Authors: S. Suissa, S. Dell'Aniello, P. Ernst

2021

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort

10.1001/jamanetworkopen.2021.5329

Authors: C. Dormuth, B. Winquist, A. Fisher, F. Wu, P. Reynier, S. Suissa, M. Dahl, Z. Ma, X. Lu, J. Zhang, C. Raymond, K. Filion, R. Platt, C. Moriello, J. Paterson

2021

Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from England

10.1111/joim.13432

Authors: J. West, T. Card, M. Bishton, P. Lanyon, L. Ban, M. Bythell, L. Elliss-Brookes, J. Manson, V. Nanduri, J. Rankin, R. Tattersall, C. Crooks

2021

Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer

10.1111/dme.14725

Authors: J. R\oikjer, N. Werkman, N. Ejskjaer, J. van den Bergh, P. Vestergaard, N. Schaper, M. Jensen, O. Klungel, F. de Vries, J. Nielen, J. Driessen, N. Ejskjaer, J. van den Bergh, P. Vestergaard, N. Schaper, Hasselstr\om Jensen, O. Klungel, F. de Vries, J. Nielen, J. Driessen, F. de Vries

2021

The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom

10.1002/iid3.495

Authors: G. Requena, J. Logie, D. Gibbons, J. Steinfeld, M. Van Dyke

2021

Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes

10.1002/cpt.2430

Authors: J. Faillie, H. Yin, O. H. Y. Yu, A. Herrero, R. Altwegg, C. Renoux, L. Azoulay

2021

Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study

10.1016/s2589-7500(21)00017-0

Authors: K. Mansfield, R. Mathur, J. Tazare, A. Henderson, A. Mulick, H. Carreira, A. Matthews, P. Bidulka, A. Gayle, H. Forbes, S. Cook, A. Wong, H. Strongman, K. Wing, C. Warren-Gash, S. Cadogan, L. Smeeth, J. Hayes, J. Quint, M. McKee, S. Langan

2021

Inequalities in incident and prevalent multimorbidity in England, 2004\textendash19: a population-based, descriptive study

10.1016/S2666-7568(21)00146-X

Authors: A. Head, K. Fleming, C. Kypridemos, P. Schofield, J. Pearson-Stuttard, M. O\textquoterightFlaherty

2021

Infection-related complications after common infection in association with new antibiotic prescribing in primary care: retrospective cohort study using linked electronic health records

10.1136/bmjopen-2020-041218

Authors: B. van Bodegraven, V. Palin, C. Mistry, M. Sperrin, A. White, W. Welfare, D. Ashcroft, T. van Staa

2021

Using electronic health records to inform trial feasibility in a rare autoimmune blistering skin disease in England

10.1186/s12874-021-01212-1

Authors: M. Persson, K. Harman, K. Thomas, J. Chalmers, Y. Vinogradova, S. Langan, J. Hippisley-Cox, S. Gran

2021

Utilization and long-term persistence of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease

10.1111/bcp.15046

Authors: A. Douros, Y. Cui, R. Platt, K. Filion, G. Sebastiani, C. Renoux

2021

The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study

10.2147/copd.s291931

Authors: G. Requena, D. Dedman, J. Quint, R. Ghosh, R. Williams, J. Pimenta

2021

Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study

10.1186/s12913-021-06762-0

Authors: L. Lix, S. Sobhan, A. St-Jean, J. Daigle, A. Fisher, O. H. Y. Yu, S. Dell'Aniello, N. Hu, S. Bugden, B. Shah, P. Ronksley, S. Alessi-Severini, A. Douros, P. Ernst, K. Filion

2021

Validity of bariatric surgery codes in the UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes Statistics

10.1002/pds.5221

Authors: T. Burkard, M. Rauch, S. Jick, C. Meier

2021

Weight change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental illness: protocol of a population-based cohort study in the UK from 1998 to 2020

10.1136/bmjopen-2021-053427

Authors: C. Lee, F. Waite, M. Smith, M. Gao, C. Bankhead, P. Aveyard, C. Piernas

2021

wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study

10.1136/bmjopen-2021-055219

Authors: B. Torlinska, J. Hazlehurst, K. Nirantharakumar, G. Thomas, J. Priestley, S. Finnikin, P. Saunders, K. Abrams, K. Boelaert

2021

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

10.1038/s41366-021-00788-4

Authors: C. Haase, S. Lopes, A. Olsen, A. Satylganova, V. Schnecke, P. McEwan

2021

What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?

10.1093/rheumatology/keab254

Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, W. Zhang, M. Doherty, M. Taal, G. Aithal, A. Abhishek

2021

Women with Polycystic Ovary Syndrome have an increased risk of major cardiovascular events: a population study

10.1210/clinem/dgab392

Authors: T. Berni, C. Morgan, D. Rees

2021

Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study

10.1007/s00198-021-05862-1

Authors: J. Erwin, D. Enki, A. Woolf